PBS approval for new once-a-day diabetes medications 9 December 2014 New once-a-day fixed-dose medications for people with type 2 diabetes have been approved for inclusion on the Pharmaceutical Benefits Scheme (PBS). The two new treatments are linagliptin with metformin (sold as Trajenta Duo), and saxagliptin with metformin (sold as Kombiglyze). Federal Health Minister Peter Dutton said that while people with type 2 diabetes already have access to the individual medications through the PBS, some need to use a combination of medicines to treat their diabetes. “With the combination dose now listed on the PBS, these patients will save up to $36.90 every time they get a script filled because they will only have to buy one fixed dose medicine instead of two,†Mr Dutton said. The new treatments are available via prescription. For more information, please contact your doctor or endocrinologist.
Partners 1 June 2026 Does your CGM meet anzCGM standards? Advertisement When you live with diabetes, glucose readings influence everyday choices: from food and exercise to conversations with your healthcare... Continue Reading
Blog 1 June 2026 Rebuilding after the fall: Brett Findlay’s story of recovery and resilience聽 Brett Findlay had just started a new job when he learnt he had type 1 diabetes. He figured he could manage diabetes by keeping his blood glucose levels consistently low. Then, one fateful day, he had a severe hypo. In this raw episode of Life on the Level, Brett talks about hypo unawareness, rebuilding after trauma, and the enduring strength of family. Continue Reading
Blog 1 June 2026 Life on the level podcast: returning for season 2聽 Life on the Level podcast is back with season 2. Hosted by young Aussies Isabella Magee and Sebastian Harris, this season explores what it's really like to live with type 1 diabetes; the challenges, the wins, and all the messy bits in between. Continue Reading
